Skip to main content
Chemfab Alkalis Ltd logo

Chemfab Alkalis Ltd — Investor Relations & Filings

Ticker · CHEMFAB ISIN · INE783X01023 LEI · 3358001VZX74GFCTZW69 BSE.NS Manufacturing
Filings indexed 392 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country IN India
Listing BSE.NS CHEMFAB

About Chemfab Alkalis Ltd

https://chemfabalkalis.com/

Chemfab Alkalis Ltd is a chemical manufacturing enterprise specializing in the chlor-alkali sector. The company primarily produces caustic soda (sodium hydroxide) in both lye and flake forms, alongside co-products such as liquid chlorine, hydrochloric acid, sodium hypochlorite, and compressed hydrogen gas. Notably, the organization was a pioneer in implementing energy-efficient membrane cell technology in its production processes. Its product portfolio serves diverse industrial applications, including water treatment, textile processing, paper and pulp manufacturing, aluminum refining, and the production of soaps and detergents. The company emphasizes operational efficiency and environmental compliance through advanced electrolysis techniques and rigorous quality control measures.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-22 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-22 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended 31st March 2026. It is a compliance certificate related to securities dematerialisation and registration, issued by the Registrar and Share Transfer Agent to the company and submitted to stock exchanges. The document is short (2812 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a certificate confirming regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2026-04-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter from Chemfab Alkalis Limited addressed to stock exchanges regarding the closure of the trading window in compliance with SEBI regulations ahead of the announcement of audited financial results for the quarter and year ended March 31, 2026. It mentions the upcoming board meeting date will be intimated later and requests the exchanges to take the information on record. The document is short (1556 characters) and serves as a regulatory announcement related to insider trading restrictions before financial results are published. It does not contain any financial data, results, or detailed report content itself. Therefore, it is best classified as a Regulatory Filing (RNS) rather than an actual financial report or earnings release.
2026-03-25 English
Credit Rating
Regulatory Filings
2026-03-14 English
Outcome of Board Meeting
Regulatory Filings
2026-02-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.